CHT105 for the Treatment of Refractory Lupus Nephritis

Conditions

• Systemic Lupus Erythematosus
• Lupus Nephritis

Interventions

• BIOLOGICAL: anti-CD19/70 CAR T cells (CHT105)

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School